Governments should not have to “break the bank” while working to achieve universal access to quality-assured and affordable essential medicines and vaccines for all, SIAPS Principal Technical Advisor Niranjan Konduri wrote in a Devex op-ed this week. Reacting to the WHO’s first global report on diabetes, released on April 6, Konduri identified inefficient government spending on pharmaceutical commodities as a driving force behind skyrocketing spending on pharmaceuticals and health commodities. Konduri suggests that governments must allocate resources wisely to promote preventive care, and should invest in health technology assessment practices to better determine spending priorities, using SIAPS Program’s evidence-based pharmaceutical financing interventions to support his points.
For more information, read the op-ed on the Devex website.
